Author:
Sturm Dietrich,Maletzki Claudia,Braun Dagmar,Emmrich Joerg
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Epstein RJ, Leung TW (2008) Tumor resensitization to erlotinib following brief substitution of cetuximab. Cancer Chemother Pharmacol 62:1111–1112
2. Wong HH, Lemoine NR (2009) Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat Rev Gastroenterol Hepatol 6:412–422
3. Uggeri F, Caprotti R, De Grate L, Crippa S, Nobili C, Penati C, Romano F (2009) Short-term preoperative IL-2 immunotherapy in operable pancreatic cancer: a randomized study. Hepatogastroenterology 56:861–865
4. Rivera F, López-Tarruella S, Vega-Villegas ME, Salcedo M (2009) Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy. Cancer Treat Rev 35:335–339
5. Oettle H, Neuhaus P (2007) Adjuvant therapy in pancreatic cancer: a critical appraisal. Drugs 67:2293–2310
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献